Clinical Trials in Tennessee

Showing 14401-14420 of 20,239 trials

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

NCT01083602

This study is designed to assess the effectiveness of the combination of Panobinostat plus Bortezomib and Dexamethasone in patients with relapsed and bortezomib refractory Multiple Myeloma.

Relapsed and Bortezomib Refractory Multiple MyelomaRefractory Multiple MyelomaMultiple Myeloma in Relapse

Novartis Pharmaceuticals55 participantsStarted Jun 2010

Los Angeles, California, United States • Stanford, California, United States • Tampa, Florida, United States +10 more locations

COMPLETEDPhase 271 miles

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

NCT00985088

The purpose of this study is to characterize the safety and immunogenicity of the H1N1 (swine) flu vaccines GSK2340273A and GSK2340274A in adults 18 years of age or older. This protocol posting has been updated for sections impacted by the Protocol amendment 1, Sept 2009.

Influenza

GlaxoSmithKline1,343 participantsStarted Oct 2009

Huntsville, Alabama, United States • Jacksonville, Florida, United States • Miami, Florida, United States +11 more locations

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Find Trials by Condition in Tennessee

Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

HOPE Demonstration Field Experiment Multisite Evaluation

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma

InterStim® Sacral Nerve Modulation Cycling Study

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

A Study of Vemurafenib in Participants With Metastatic Melanoma

Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness